slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 1,681-1,710
Pages 1,437
Rows per page 30
Arc
1,681-1,710 of 43,093
10
Apollo Global Management | Results Presentation Deck | 41 slidesApollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction2 hits
11
Includes footnotes regarding Fund X catch-up fees and non-compensation expenses.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction2 hits
04
The slide uses a Gantt-style visualization to show drug development progress across Preclinical, Phase 1, Phase 2, and Phase 3 stages.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
05
The slide uses a table-like structure to track progress (checkmarks for completed, squares for upcoming) across 8 distinct drug programs.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
07
Includes two line charts showing PK and PD profiles across different dosage levels.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
08
The slide outlines a 12-week open-label study with a specific focus on treatment-resistant depression (TRD).ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
09
The slide uses a timeline-based process diagram to illustrate the clinical trial flow.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
10
The slide features a stylized portrait of a person, likely a patient or representative, within a circular frame.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
11
Includes a map of global disease burden and key product features.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
12
The slide cites a third-party study (Palhano-Fontes et al.) as proxy evidence for DMT efficacy.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
13
The slide uses a process flow diagram to show the progression of the trial parts.ATAI | Investor Presentation Deck | 34 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
05
Crocs | Investor Presentation Deck | 29 slidesCrocs | Investor Presentation Deck | 29 slides · Crocs
Pitch deck Investor relations Beat · Business Model2 hits
06
The chart highlights Crocs in green to distinguish it from the grey peer bars.Crocs | Investor Presentation Deck | 29 slides · Crocs
Pitch deck Investor relations Beat · Business Model2 hits
07
The chart highlights Crocs' superior margin performance relative to competitors.Crocs | Investor Presentation Deck | 29 slides · Crocs
Pitch deck Investor relations Beat · Business Model2 hits
08
The title mentions $160B+ while the chart labels the market as ~$305B, suggesting the $160B might refer to a specific subset or a different scope.Crocs | Investor Presentation Deck | 29 slides · Crocs
Pitch deck Investor relations Beat · Market Size2 hits
09
The sustainability section uses a circular graphic to emphasize the 'Net Zero by 2040' goal.Crocs | Investor Presentation Deck | 29 slides · Crocs
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
08
Uses a visual growth projection (circles) to represent market expansion.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain2 hits
08
Uses a combination of clinical trial data (VISION) and market projections to justify the TAM for FPI-2265.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution2 hits
31
The slide uses a circular process diagram to represent the platform's core functions and connects them to specific industry pain points.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · Solution2 hits
32
The slide uses a flywheel-style circular process diagram to represent the platform's value proposition.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · Solution2 hits
40
Uses screenshots of news articles as evidence of market trends.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
21
Lionsgate | SPAC Presentation Deck | 35 slidesLionsgate | SPAC Presentation Deck | 35 slides · Lionsgate
Pitch deck Investment bank Beat · FinancialsLoop · Benchmark Gap2 hits
22
Includes detailed footnotes explaining valuation assumptions and share counts.Lionsgate | SPAC Presentation Deck | 35 slides · Lionsgate
Pitch deck Investment bank Beat · FinancialsLoop · Benchmark Gap2 hits
07
The slide features a split layout with a left-hand column for advisors/board and a right-hand grid for the leadership team, plus a footer highlighting 12 prior FDA approvals.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Solution2 hits
09
The slide uses a structured table to contrast two distinct patient populations (ALK+ vs ROS1+) across three lines of therapy (1L, 2L, 3L+).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
09
Includes two line charts showing tumor volume reduction over time and a table showing patient incidence for target indications.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
12
The slide uses a patient selection strategy based on ARID1a mutation status.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction2 hits
06
Includes definitions for subscriber metrics and the fiscal period end date.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · ProblemLoop · So What Cascade2 hits
09
The slide uses a four-column layout to showcase brand logos under specific value propositions.SiriusXM | Investor Presentation Deck | 20 slides · SiriusXM
Conference presentation Investor relations Beat · Product2 hits
07
South Plains Financial | Results Presentation Deck | 25 slidesSouth Plains Financial | Results Presentation Deck | 25 slides · South Plains Financial
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction2 hits